Why Join Us?

As a member of the Parabilis Medicines team, you will be a part of an organization dedicated to creating extraordinary medicines for diseases with urgent unmet needs, harnessing our proprietary peptide platform to transform treatment possibilities for patients. Parabilis is a clinical-stage biopharmaceutical company dedicated to unlocking high-impact protein targets long-considered undruggable. The company has developed a new class of stabilized, cell-penetrant alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that are inaccessible to traditional drug modalities.

Headquartered in Cambridge, Mass., Parabilis is advancing a focused pipeline of multiple first-in-class therapies across both rare and common cancers. Its lead asset, zolucatetide (FOG-001), is a first-in-class, clinically validated direct inhibitor of the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors, implicated in millions of cancer cases annually, including in colorectal cancer, desmoid tumors, hepatocellular carcinoma and a range of other Wnt/β-catenin-driven tumors. In Phase 1 clinical trials, zolucatetide produced the first-ever clinical evidence that it can directly inhibit this interaction, once previously considered “undruggable” despite its role across multiple cancer types. Parabilis is also advancing investigational degraders of ERG and ARON into clinical development for the treatment of prostate cancer, as well as progressing other preclinical programs. Backed by a recent $305 million Series F financing, Parabilis is entering an exciting phase of growth and execution.

What’s the opportunity?

The VP, Development Data Science will build and lead a cross functional data centric matrix to accelerate drug development, support regulatory submissions and guide the Real-World Data (RWD) / Real-World Evidence (RWE) function at Parabilis. This role is responsible for end-to-end strategy and execution of RWD/RWE and clinical data science to inform trial design, contextualize clinical results, support biomarker and translational work, and optimize site and patient selection.

The VP will partner closely with Clinical Development, Clinical Operations, Biostatistics, Translational/Computational Biology, Regulatory, and the broader Data Science & Engineering team to maximize the probability of success of our clinical programs.

• Strategy & Leadership
  • Define and own the Clinical Data Science strategy.
  • Serve as the senior Clinical Data Science leader and primary point of contact for RWD/RWE across programs aligned with portfolio and corporate objectives.
  • Represent Clinical Data Science on cross-functional governance and portfolio forums.
• RWD/RWE & Clinical Analytics
  • Design and oversee RWE studies to contextualize clinical trials, including synthetic/external control arms, patient matching, and trial emulation.
  • Use RWD to inform clinical trial design (eligibility criteria, endpoints, enrichment strategies), dose/regimen selection, and go/no-go decisions.
  • Contribute data science insights for feasibility and site selection, including epidemiology, patient journeys, referral patterns, and diversity/access.
  • Integrate RWD with internal clinical and biomarker data to support forward and reverse translation, target and indication strategy, and mechanism-of-resistance analyses.
  • Establish and maintain best practices in causal inference, comparative effectiveness, and time-to-event modeling relevant to RWE in oncology.
• Data Assets, Partnerships & Infrastructure
  • Identify, evaluate, and prioritize RWD sources (EHR, claims, registries, genomic/omic datasets, imaging, PROs) to support current and future clinical needs.
  • Lead collaboration and contracting with RWD providers and academic/industry partners in coordination with Commercial, Business Development, Legal, and Procurement.
  • Partner with Engineering and Data Science to define requirements for secure, scalable, compliant RWD infrastructure and analytic environments.
  • Ensure data quality, interoperability, and governance suitable for regulatory-grade analyses.
• Team Building & Management
  • Build and lead a high-performing Clinical Data Science team (e.g., RWE epidemiologists, clinical data scientists, etc).
  • Set clear objectives, provide regular feedback, and support growth and succession planning.
  • Foster a culture of scientific rigor, transparency, and effective collaboration with Clinical Development, Biostatistics, and other partners.
• Cross-Functional Collaboration & Communication
  • Work in an integrated way with Clinical and Development teams to define key questions and translate them into analytic and RWE plans.
  • Communicate complex methods, assumptions, and results clearly to clinical, technical, and executive stakeholders.
  • Support regulatory and payer/Health Technology Assessment interactions where RWE and clinical analytics contribute to program strategy (e.g., briefing documents, responses, meeting preparation).
  • Collaborate with Translational and Computational Biology to align biomarker and patient selection strategies with integrated clinical and RWD analytics.
• Governance, Quality & Compliance
  • Ensure RWD/RWE activities meet regulatory, ethical, and privacy standards (e.g., GCP, data de-identification and privacy requirements).
  • Implement documentation, reproducibility, and quality standards for Clinical Data Science analyses.
  • Monitor evolving external expectations for use of RWE in regulatory and payer settings and adapt internal practices accordingly.

What you’ll need to be successful:

• PhD, MD, PharmD, or MS in Epidemiology, Biostatistics, HEOR, Data Science, or a related quantitative field.
• 12–15+ years of experience in pharma/biotech, healthcare technology, or related sectors, with significant focus on RWD/RWE and clinical development; oncology experience strongly preferred.
• Proven track record designing and delivering impactful RWE studies to inform clinical, regulatory, or payer decision-making.
• Strong understanding of clinical trial design, biostatistics fundamentals, and translational/biomarker concepts, ideally in oncology or immuno-oncology.
• Demonstrated experience building, leading, and developing high-performing quantitative teams in a matrixed environment.
• Hands-on familiarity with major RWD types (EHR, claims, registries, genomic/omic datasets) and key vendors/platforms.
• Proficiency with modern analytic tools and programming environments (e.g., R, Python, SQL) and with guiding development of robust, reproducible analytic workflows.
• Excellent communication and influencing skills with the ability to engage effectively with clinicians, statisticians, senior leaders, and external partners.

Core Values

Parabilis Medicines is a team of passionate pioneers who are trailblazing the future of precision medicine with the aim of making a meaningful difference in the lives of patients. The company is committed to promoting an inspiring and flourishing working environment for all employees across the business, in all departments, and driving innovation for patient benefit.

• Growth-Minded. We’re inventing a new class of medicines—one applicable to therapeutic targets that have been dreamt about, but always considered impossible to drug. Our work requires us to be curious, humble and adaptable.
• In(ter)dependent. We are fiercely independent as a leader in defying the limitations of current therapeutic modalities, and interdependent as a team as we work collaboratively to shift drug discovery paradigms and provide patients with better treatment options.
• Patient-focused. We are deeply focused on patient outcomes, and all energy in the company is focused on science as it translates to patient impact.
• All-In. We’re All-In on solving some of the hardest scientific challenges and delivering one of the most effective new classes of drugs in history.

The base salary range for this position is $325,000-$380,000 per year, depending on experience, qualifications, and internal practices. Parabilis’s total compensation package also includes an annual target bonus, equity, and a comprehensive suite of competitive benefits designed to support our employees’ overall well-being.

As an equal opportunity employer, Parabilis Medicines values an inclusive workplace and welcomes applicants of all backgrounds and experiences. All qualified applicants will receive consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other factors prohibited by law.

30 Acorn Park Drive    |     Cambridge, MA 02140    |    www.parabilismed.com

Why Join Us?

As a member of the Parabilis Medicines team, you will be a part of an organization dedicated to creating extraordinary medicines for diseases with urgent unmet needs, harnessing our proprietary peptide platform to transform treatment possibilities for patients. Parabilis is a clinical-stage biopharmaceutical company dedicated to unlocking high-impact protein targets long-considered undruggable. The company has developed a new class of stabilized, cell-penetrant alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that are inaccessible to traditional drug modalities.

Headquartered in Cambridge, Mass., Parabilis is advancing a focused pipeline of multiple first-in-class therapies across both rare and common cancers. Its lead asset, zolucatetide (FOG-001), is a first-in-class, clinically validated direct inhibitor of the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors, implicated in millions of cancer cases annually, including in colorectal cancer, desmoid tumors, hepatocellular carcinoma and a range of other Wnt/β-catenin-driven tumors. In Phase 1 clinical trials, zolucatetide produced the first-ever clinical evidence that it can directly inhibit this interaction, once previously considered “undruggable” despite its role across multiple cancer types. Parabilis is also advancing investigational degraders of ERG and ARON into clinical development for the treatment of prostate cancer, as well as progressing other preclinical programs. Backed by a recent $305 million Series F financing, Parabilis is entering an exciting phase of growth and execution.

What’s the opportunity?

We are seeking an experienced leader in vivarium and in vivo operations to oversee our research animal facilities and in vivo study support. In this Associate Director role, you will be accountable for daily operations, resource planning, budgets, technical training and compliance with IACUC, AAALAC and institutional policies. 

You will manage animal procurement, housing, husbandry services and technicalsupport across discovery and pre‑clinicalstudies, collaborating with program leaders and CRO partnersto align operationalsupport with scientific objectives. A key aspect of this role is developing and coaching a high‑performing technical team while driving operational excellence and continuous improvement to uphold the highest standards of animal welfare.

Key abilities of this role include:

• Provide strategic and operational leadership for vivarium operations, ensuring high-quality husbandry, facility maintenance, and resource planning.
• Serve as institutional lead for IACUC protocols and animal use compliance; prepare and lead facility audits and inspections.
• Oversee procurement and inventory of animals and supplies and maintain accurate records of census and environmental conditions.
• Develop and manage the vivarium operating budget, forecasting resource needs and supporting capital planning. 
• Provide oversight and coordination of in vivo hands on training and SOP adherence for a cross functional group of hybrid scientists; remain willing to perform hands on work as needed and lead the integration of new skills and techniques as our portfolio and programs expand. 
• Coordinate study scheduling and operational support across in vivo pharmacology programs and CRO partners; represent in vivo operations in cross-functional meetings.
• Drive process improvement, SOP development and emergency preparedness; ensure compliance with AAALAC and institutional policies.
• Provide subject matter expertise in in vivo study execution, facility operations, and support program teams by troubleshooting logistics.

What you’ll need to be successful:

• Bachelor’s or master’s degree in biological sciences, animal science or related discipline; 10+ years of vivarium/in vivo experience including 5+ years in a leadership role; advanced degree (M.S., DVM or Ph.D.) and AALAS/CMAR certification are preferred.
• Demonstrated success managing vivarium operations, including budgets, resource forecasting, animal procurement and facility maintenance.
• In depth knowledge of AAALAC and IACUC regulations and experience serving as institutional lead for animal use protocols and facility audits.
• Proven ability to supervise, mentor, and develop technical staff and maintain high standards of animal welfare and safety.
• Strong operational planning, problem-solving and process improvement skills, with experience developing SOPs and emergency plans. 
• Excellent communication and interpersonal skills and ability to collaborate across cross functional program teams and with CRO partners.
• Ability to thrive in a fast paced, collaborative environment, work on site and participate in weekend or holiday coverage as needed.

Core Values

Parabilis Medicines is a team of passionate pioneers who are trailblazing the future of precision medicine with the aim of making a meaningful difference in the lives of patients. The company is committed to promoting an inspiring and flourishing working environment for all employees across the business, in all departments, and driving innovation for patient benefit.

• Growth-Minded. We’re inventing a new class of medicines—one applicable to therapeutic targets that have been dreamt about, but always considered impossible to drug. Our work requires us to be curious, humble and adaptable.
• In(ter)dependent. We are fiercely independent as a leader in defying the limitations of current therapeutic modalities, and interdependent as a team as we work collaboratively to shift drug discovery paradigms and provide patients with better treatment options.
• Patient-focused. We are deeply focused on patient outcomes, and all energy in the company is focused on science as it translates to patient impact.
• All-In. We’re All-In on solving some of the hardest scientific challenges and delivering one of the most effective new classes of drugs in history.

The base salary range for this position is $165,000-$200,000, depending on experience, qualifications, and internal practices. Parabilis’s total compensation package also includes an annual target bonus, equity, and a comprehensive suite of competitive benefits designed to support our employees’ overall well-being.

As an equal opportunity employer, Parabilis Medicines values an inclusive workplace and welcomes applicants of all backgrounds and experiences. All qualified applicants will receive consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other factors prohibited by law.

30 Acorn Park Drive    |     Cambridge, MA 02140    |    www.parabilismed.com

Why Join Us?

Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines that unlock high-impact protein targets long-considered undruggable. The company has developed a new class of stabilized, cell-penetrant alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that are inaccessible to traditional drug modalities.

Headquartered in Cambridge, Mass., Parabilis is advancing a focused pipeline of multiple first-in-class therapies across both rare and common cancers. Its lead asset, zolucatetide (FOG-001), is a first-in-class, clinically validated direct inhibitor of the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors, implicated in millions of cancer cases annually, including in colorectal cancer, desmoid tumors, hepatocellular carcinoma and a range of other Wnt/β-catenin-driven tumors. In Phase 1 clinical trials, zolucatetide produced the first-ever clinical evidence that it can directly inhibit this interaction, once previously considered “undruggable” despite its role across multiple cancer types. Parabilis is also advancing investigational degraders of ERG and ARON into clinical development for the treatment of prostate cancer, as well as progressing other preclinical programs. Backed by a recent $305 million Series F financing, Parabilis is entering an exciting phase of growth and execution.

What’s the opportunity?

This is a rare opportunity to shape and protect the intellectual foundation of a company redefining what’s possible in drug discovery. As Director, Intellectual Property, you will architect and lead the global IP strategy for Parabilis’ Helicon™ platform and pipeline—helping unlock the full value of therapies targeting proteins long considered “undruggable.”

Reporting to the General Counsel, you will operate at the intersection of cutting-edge science and business strategy, partnering closely with Research, Development, CMC, and Business Development to translate breakthrough innovation into durable competitive advantage.

In this highly visible role, you will not only build and scale world-class IP for the organization but also serve as a key strategic advisor to senior leadership—guiding critical decisions across pipeline advancement, partnerships, and long-term value creation.

Key Responsibilities:

• Develop and execute global patent strategies aligned with corporate, R&D, and business objectives.
• Design layered IP protection strategies covering composition of matter, methods of treatment, platform technologies, computational methods, and manufacturing.
• Lead drafting and prosecution of U.S. and international patent applications.
• Conduct invention mining sessions and proactively identify patentable subject matter.
• Oversee global prosecution strategy and manage outside counsel.
• Lead freedom-to-operate analyses and patent landscape assessments.
• Support due diligence for partnerships, collaborations, and financing transactions.
• Serve as primary IP advisor to Research, Clinical, Regulatory, CMC, and Business Development teams.
• Manage IP budgets and implement scalable portfolio tracking systems.
• Present IP strategy updates to senior leadership and Board as needed.

What you’ll need to be successful:

• Ph.D. in chemistry, biochemistry, molecular biology, structural biology, peptide chemistry, protein engineering, or related discipline strongly preferred.
• Registered U.S. Patent Agent or admitted U.S. Patent Attorney in good standing.
• 5+ years of patent experience in biotechnology, including in-house or law firm experience supporting innovative therapeutic platforms.
• Strong familiarity with peptide therapeutics, intracellular delivery systems, oncology drug discovery, and computational drug discovery technologies.
• Demonstrated success building patent estates for platform biotech companies.
• Deep understanding of U.S. and global patent law relevant to life sciences.
• Excellent scientific writing, claim drafting, and strategic communication skills.
• Demonstrated ability to utilize AI tools for day-to-day work; baseline proficiency is expected, and advanced or innovative use of AI is a strong plus.
• Ability to work hybrid preferred; remote considered.

Core Values

Parabilis Medicines is a team of passionate pioneers who are trailblazing the future of precision medicine with the aim of making a meaningful difference in the lives of patients. The company is committed to promoting an inspiring and flourishing working environment for all employees across the business, in all departments, and driving innovation for patient benefit.

• Growth-Minded. We’re inventing a new class of medicines—one applicable to therapeutic targets that have been dreamt about, but always considered impossible to drug. Our work requires us to be curious, humble and adaptable.
• In(ter)dependent. We are fiercely independent as a leader in defying the limitations of current therapeutic modalities, and interdependent as a team as we work collaboratively to shift drug discovery paradigms and provide patients with better treatment options.
• Patient-focused. We are deeply focused on patient outcomes, and all energy in the company is focused on science as it translates to patient impact.
• All-In. We’re All-In on solving some of the hardest scientific challenges and delivering one of the most effective new classes of drugs in history.

The base salary range for this position is $220,000-$290,000 per year, depending on experience, qualifications, and internal practices. Parabilis’s total compensation package also includes an annual target bonus, equity, and a comprehensive suite of competitive benefits designed to support our employees’ overall well-being.

As an equal opportunity employer, Parabilis Medicines values an inclusive workplace and welcomes applicants of all backgrounds and experiences. All qualified applicants will receive consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other factors prohibited by law.

30 Acorn Park Drive    |     Cambridge, MA 02140    |    www.parabilismed.com

Why Join Us?

Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines that unlock high-impact protein targets long-considered undruggable. The company has developed a new class of stabilized, cell-penetrant alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that are inaccessible to traditional drug modalities. 

Headquartered in Cambridge, Mass., Parabilis is advancing a focused pipeline of multiple first-in-class therapies across both rare and common cancers. Its lead asset, zolucatetide (FOG-001), is a first-in-class, clinically validated direct inhibitor of the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors, implicated in millions of cancer cases annually, including in colorectal cancer, desmoid tumors, hepatocellular carcinoma and a range of other Wnt/β-catenin-driven tumors. In Phase 1 clinical trials, zolucatetide produced the first-ever clinical evidence that it can directly inhibit this interaction, once previously considered “undruggable” despite its role across multiple cancer types. Parabilis is also advancing investigational degraders of ERG and AR^ON into clinical development for the treatment of prostate cancer, as well as progressing other preclinical programs. Backed by a recent $305 million Series F financing, Parabilis is entering an exciting phase of growth and execution.

What’s the opportunity?

The Senior Manager, Supply Chain will lead the end-to-end operational management of investigational product (IP) and clinical trial materials across global Phase I–III studies. This role is responsible for ensuring timely, compliant, and efficient delivery of clinical supplies, while partnering cross-functionally with Clinical Operations, Quality, Regulatory, CMC, and external vendors to support study execution.

• Develop and maintain study-level supply plans and forecasts aligned with enrollment, protocol design, and site activation timelines
• Coordinate packaging, labeling, release, and global distribution of investigational products and ancillary materials
• Oversee inventory across depots and study sites, proactively mitigating risks to avoid shortages or excess
• Serve as business owner of the IRT system, including setup, configuration, validation, and ongoing management
• Partner cross-functionally to align supply strategy with clinical and regulatory requirements and ensure seamless execution
• Author and maintain supply-related documentation, including SOPs, Pharmacy Manuals, and study-specific materials
• Ensure compliance with GxP, GDP, and ICH-GCP standards, supporting audits and inspection readiness
• Manage global logistics, vendor oversight, and third-party partners to ensure uninterrupted supply across regions

What you’ll need to be successful:

• Bachelor’s degree in Supply Chain, Life Sciences, or related field (Master’s preferred)
• Minimum 5 years of global clinical supply chain experience within biotech, pharma, or medical device
• Hands-on experience with IRT/IXRS systems (e.g., 4G Clinical, Almac, Endpoint)
• Experience supporting global Phase I–III clinical trials (commercial launch experience preferred)
• Proficiency with Microsoft Office and inventory/ERP systems
• Strong understanding of GxP, GDP, and ICH-GCP regulations
• Proven ability to manage complex global supply operations and mitigate risk
• Strong analytical, organizational, and problem-solving skills
• Effective cross-functional collaboration and communication across internal teams and external partners
• Experience drafting SOPs, Pharmacy Manuals, and clinical supply documentation preferred
• Familiarity with cold chain and temperature-controlled distribution preferred
• APICS/CSCP or PMP certification a plus
• Demonstrated ability to utilize AI tools for day-to-day work; baseline proficiency is expected, and advanced or innovative use of AI is a strong plus
• Able to work on-site and attend in-person meetings
• Ability to travel up to 15%

Core Values

Parabilis is a team of passionate pioneers who are trailblazing the future of precision medicine with the aim of making a meaningful difference in the lives of patients. The company is committed to promoting an inspiring and flourishing working environment for all employees across the business, in all departments, and driving innovation for patient benefit.

• Growth-Minded. We’re inventing a new class of medicines—one applicable to therapeutic targets that have been dreamt about, but always considered impossible to drug. Our work requires us to be curious, humble and adaptable.
• In(ter)dependent.We are fiercely independent as a leader in defying the limitations of current therapeutic modalities, and interdependent as a team as we work collaboratively to shift drug discovery paradigms and provide patients with better treatment options.
• Patient-focused.We are deeply focused on patient outcomes, and all energy in the company is focused on science as it translates to patient impact.
• All-In.We’re All-In on solving some of the hardest scientific challenges and delivering one of the most effective new classes of drugs in history.

The base salary target for this position is $153,000-$180,000 per year, depending on experience, qualifications, and internal practices. Parabilis’s total compensation package also includes an annual target bonus, equity, and a comprehensive suite of competitive benefits designed to support our employees’ overall well-being.

As an equal opportunity employer, Parabilis values an inclusive workplace and welcomes applicants of all backgrounds and experiences. All qualified applicants will receive consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other factors prohibited by law.

30 Acorn Park Drive    |     Cambridge, MA 02140    |    www.parabilismed.com

Why Join Us?

Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines that unlock high-impact protein targets long-considered undruggable. The company has developed a new class of stabilized, cell-penetrant alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that are inaccessible to traditional drug modalities. 

Headquartered in Cambridge, Mass., Parabilis is advancing a focused pipeline of multiple first-in-class therapies across both rare and common cancers. Its lead asset, zolucatetide (FOG-001), is a first-in-class, clinically validated direct inhibitor of the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors, implicated in millions of cancer cases annually, including in colorectal cancer, desmoid tumors, hepatocellular carcinoma and a range of other Wnt/β-catenin-driven tumors. In Phase 1 clinical trials, zolucatetide produced the first-ever clinical evidence that it can directly inhibit this interaction, once previously considered “undruggable” despite its role across multiple cancer types. Parabilis is also advancing investigational degraders of ERG and AR^ON into clinical development for the treatment of prostate cancer, as well as progressing other preclinical programs. Backed by a recent $305 million Series F financing, Parabilis is entering an exciting phase of growth and execution.

What’s the opportunity?

The Senior Associate Scientist will play a hands-on role in discovery and translational biology, leading assay development and generating mechanistic insights to support oncology programs from lead optimization through biomarker development. This individual will partner cross-functionally to deliver high-quality, decision-driving data and contribute to advancing novel targets.

• Design, develop, and optimize multiplexed cell-based and high-throughput assays to ensure robust, reproducible, and scalable data generation
• Improve assay throughput and efficiency through automation or semi-automation, proactively identifying risks and refining experimental strategies
• Drive mechanistic understanding of novel oncology targets through hypothesis-driven experimentation (e.g., CRISPR, knockdown, tool compounds, rescue strategies)
• Integrate internal data, literature, and public datasets to inform experimental design, interpret results, and refine scientific hypotheses
• Contribute to biomarker discovery efforts and support translational strategy development
• Collaborate cross-functionally with chemistry, DMPK, in vivo pharmacology, and data science teams to advance programs from hit-to-lead through IND-enabling studies
• Support assay transfer to CROs, including data review, troubleshooting, and performance tracking
• Present findings clearly to project teams and maintain rigorous documentation, including ELN entries and SOP development

What you’ll need to be successful:

• Education & Experience:
  • Bachelor’s degree with 5+ years or Master’s degree with 4+ years of industry experience in a relevant field
  • Experience in discovery biology, with exposure to oncology or related therapeutic areas preferred
• Technical Expertise:
  • Strong hands-on experience developing and executing cell-based and high-throughput assays, including automation
  • Quantitative approach to assay design and data quality (controls, reproducibility, robustness metrics)
  • Experience designing and executing experiments independently and generating actionable insights from complex datasets
  • Familiarity with a subset of the following:
    • CRISPR/Cas9, gene editing/knockdown, overexpression systems
    • qPCR/RT-qPCR, Western blotting, flow cytometry
    • Reporter assays (e.g., luciferase, NanoBRET), protein–protein interaction assays
    • Mammalian cell culture and functional assays (e.g., proliferation, apoptosis)
    • High-throughput screening formats (e.g., 384-well)
    • Omics approaches (e.g., RNA-seq, proteomics) preferred
    • Automation platforms, ELN systems (e.g., Dotmatics), and SOP authorship
  • Core Capabilities:
    • Strong experimental rigor and data-driven decision-making
    • Ability to manage multiple projects and priorities in a fast-paced environment
    • Effective cross-functional collaboration and clear scientific communication
    • Ownership mindset with ability to independently drive workstreams
  • Demonstrated ability to utilize AI tools for day-to-day work; baseline proficiency is expected, and advanced or innovative use of AI is a strong plus
  • Able to work on-site and attend in-person meetings

Core Values

Parabilis Medicines is a team of passionate pioneers who are trailblazing the future of precision medicine with the aim of making a meaningful difference in the lives of patients. The company is committed to promoting an inspiring and flourishing working environment for all employees across the business, in all departments, and driving innovation for patient benefit.

• Growth-Minded. We’re inventing a new class of medicines—one applicable to therapeutic targets that have been dreamt about, but always considered impossible to drug. Our work requires us to be curious, humble and adaptable.
• In(ter)dependent. We are fiercely independent as a leader in defying the limitations of current therapeutic modalities, and interdependent as a team as we work collaboratively to shift drug discovery paradigms and provide patients with better treatment options.
• Patient-focused. We are deeply focused on patient outcomes, and all energy in the company is focused on science as it translates to patient impact.
• All-In. We’re All-In on solving some of the hardest scientific challenges and delivering one of the most effective new classes of drugs in history.

The base salary range for this position is $88,000–$108,000 per year, depending on experience, qualifications, and internal practices. Parabilis’s total compensation package also includes an annual target bonus, equity, and a comprehensive suite of competitive benefits designed to support our employees’ overall well-being.

As an equal opportunity employer, Parabilis Medicines values an inclusive workplace and welcomes applicants of all backgrounds and experiences. All qualified applicants will receive consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other factors prohibited by law.

30 Acorn Park Drive    |     Cambridge, MA 02140    |    www.parabilismed.com

Why Join Us?

As a member of the Parabilis Medicines team, you will be a part of an organization dedicated to creating extraordinary medicines for diseases with urgent unmet needs, harnessing our proprietary peptide platform to transform treatment possibilities for patients. Parabilis is a clinical-stage biopharmaceutical company dedicated to unlocking high-impact protein targets long-considered undruggable. The company has developed a new class of stabilized, cell-penetrant alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that are inaccessible to traditional drug modalities.

Headquartered in Cambridge, Mass., Parabilis is advancing a focused pipeline of multiple first-in-class therapies across both rare and common cancers. Its lead asset, zolucatetide (FOG-001), is a first-in-class, clinically validated direct inhibitor of the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors, implicated in millions of cancer cases annually, including in colorectal cancer, desmoid tumors, hepatocellular carcinoma and a range of other Wnt/β-catenin-driven tumors. In Phase 1 clinical trials, zolucatetide produced the first-ever clinical evidence that it can directly inhibit this interaction, once previously considered “undruggable” despite its role across multiple cancer types. Parabilis is also advancing investigational degraders of ERG and ARON into clinical development for the treatment of prostate cancer, as well as progressing other preclinical programs. Backed by a recent $305 million Series F financing, Parabilis is entering an exciting phase of growth and execution.

What’s the opportunity?

We are seeking a Scientist with a chemical biology mindset and strong experimental skills to help advance and scale our AI-driven peptide discovery programs. Parabilis has built a powerful high-throughput mass-spec driven multiplexed screening platform that enables us to navigate chemical space and optimize our Helicons to target undruggable proteins. In this role, you will develop and improve experimental methods for understanding Helicon activity and properties, leveraging a range of laboratory and computational tools, and collaborating as part of a cross-functional team. Over time, you will develop an understanding of Helicon design and leverage high-quality assay data to advance drug discovery programs.

Specific responsibilities include:

• Develop and improve experimental screening assays: design, optimize, and productionize biochemical and cell-based assays that allow us to measure drug-like properties at scale across multiple programs.
• Advance automation in practice: implement automation for existing assays, and construct new assays with laboratory robotics in mind, troubleshooting and iterating workflows to achieve consistent performance and to facilitate integration with digital and AI/agent-driven automation.
• Build script-based tools to scale execution: develop reusable scripts and lightweight tools that reduce manual steps and improve experiment setup, tracking, QC, and reporting for broad team use.
• Drive decision-quality data and learning: apply quantitative rigor to assay performance and data QC and translate outputs into insights that inform next experiments and, over time, Helicon optimization.  
  

What you’ll need to be successful:

Required qualifications

• PhD in Chemical Biology, Biochemistry, Cell Biology, or a related discipline, with 2-4 years of postdoctoral and/or industry experience.
• Strong hands-on experience developing, optimizing, and executing experimental assays (biochemical, biophysical, and/or cell-based), with demonstrated ability to translate complex biological questions into robust, scalable assay formats.
• Quantitative approach to assay quality and performance, including comfort with controls, variability, robustness, and data QC to produce decision-quality readouts.
• Demonstrated scripting and tool-building experience beyond ad hoc “vibe coding,” with examples of using code to automate analyses, streamline workflows, or solve recurring operational problems.
• Ability to work cross-functionally and communicate clearly with chemistry, biology, and data-focused colleagues.
• Demonstrated use of AI tools in your current role and responsibilities is required; advanced or innovative use is a plus.

Preferred qualifications

• Experience improving lab throughput through automation or semi-automation, or strong aptitude and interest in learning and applying automation technologies in a screening environment.
• Familiarity with high-throughput screening concepts and scaling assay workflows to support large sample numbers.
• Working knowledge of peptide chemistry and/or peptide discovery concepts is a plus but not required.

Ways of working that matter here

• A builder mindset with strong scientific judgment: you identify bottlenecks, choose the least-resistant path to improvement, and execute with urgency.
• Curiosity for emerging technologies and a practical approach to evaluating what could improve workflow robustness, automation, or assay quality.
• Highly collaborative, low-ego, can-do attitude with consistent follow-through and strong ownership of results.

Core Values

Parabilis is a team of passionate pioneers who are trailblazing the future of precision medicine with the aim of making a meaningful difference in the lives of patients. The company is committed to promoting an inspiring and flourishing working environment for all employees across the business, in all departments, and driving innovation for patient benefit.

• Growth-Minded. We’re inventing a new class of medicines—one applicable to therapeutic targets that have been dreamt about, but always considered impossible to drug. Our work requires us to be curious, humble and adaptable.
• In(ter)dependent. We are fiercely independent as a leader in defying the limitations of current therapeutic modalities, and interdependent as a team as we work collaboratively to shift drug discovery paradigms and provide patients with better treatment options.
• Patient-focused. We are deeply focused on patient outcomes, and all energy in the company is focused on science as it translates to patient impact.
• All-In. We’re All-In on solving some of the hardest scientific challenges and delivering one of the most effective new classes of drugs in history.

The base salary range for this position is [$120,000–$145,000] per year, depending on experience, qualifications, and internal practices. Parabilis’s total compensation package also includes an annual target bonus, equity, and a comprehensive suite of competitive benefits designed to support our employees’ overall well-being.

As an equal opportunity employer, Parabilis values an inclusive workplace and welcomes applicants of all backgrounds and experiences. All qualified applicants will receive consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other factors prohibited by law.

Why Join Us?

As a member of the Parabilis Medicines team, you will be a part of an organization dedicated to creating extraordinary medicines for diseases with urgent unmet needs, harnessing our proprietary peptide platform to transform treatment possibilities for patients. Parabilis is a clinical-stage biopharmaceutical company dedicated to unlocking high-impact protein targets long-considered undruggable. The company has developed a new class of stabilized, cell-penetrant alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that are inaccessible to traditional drug modalities. 

Headquartered in Cambridge, Mass., Parabilis is advancing a focused pipeline of multiple first-in-class therapies across both rare and common cancers. Its lead asset, zolucatetide (FOG-001), is a first-in-class, clinically validated direct inhibitor of the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors, implicated in millions of cancer cases annually, including in colorectal cancer, desmoid tumors, hepatocellular carcinoma and a range of other Wnt/β-catenin-driven tumors. In Phase 1 clinical trials, zolucatetide produced the first-ever clinical evidence that it can directly inhibit this interaction, once previously considered “undruggable” despite its role across multiple cancer types. Parabilis is also advancing investigational degraders of ERG and AR^ON into clinical development for the treatment of prostate cancer, as well as progressing other preclinical programs. Backed by a recent $305 million Series F financing, Parabilis is entering an exciting phase of growth and execution.

What’s the opportunity?

The Vice President of Biometry will lead Parabilis’s biometrics organization, overseeing biostatistics, statistical programming, data management, clinical data science and Real-World Data to support clinical development programs from early-phase through regulatory submission. This strategic role ensures the integrity, quality, and compliance of all clinical trial data and analyses while driving innovation in data strategy and statistical methodologies. Reporting to our SVP, Development Operations, the successful candidate will serve as a key member of the Development leadership team, partnering closely with Clinical Development, Clinical Operations, Regulatory Affairs, translational/computational biology and other functions to enable data-driven decision-making and successful product development.

• Lead and develop the Biometrics organization, including biostatistics, programming, data management Clinical Data science ensuring high-quality deliverables across all clinical programs and fostering a culture of scientific rigor, accountability, collaboration and innovation.
• Oversee design and implementation of statistical methodologies for clinical trials.
• Champion innovative methodologies, including adaptive and model-based approaches, to support efficient and agile drug development.
• Provide strategic input into drug development strategies in collaboration with program-level and functional leadership, working closely with Clinical Development, Clinical Operations, and Translational Medicine.
• Ensure the integrity, high quality and traceability of clinical trial data and the accuracy of all statistical analyses, leading to compliant deliverables in biometry.
• Lead and support biometrics interactions with global health authorities.
• Establish and maintain vendor partnerships ensuring quality and timely delivery of outsources biometrics activities.

What you’ll need to be successful:

• Doctoral degree in Biostatistics or related field.
• 15+ years of biometrics experience within the biotech or pharmaceutical field.
• Proven track record of leading, building, and managing teams.
• Demonstrated record of fostering creativity, productivity, and execution with urgency, teamwork and accountability.
• Company leader who leads by example, employs expertise and influence to encourage collaboration across departments, levels, and groups to achieve key objectives.
• Deep knowledge of clinical trial design, regulatory requirements, and statistical environment.
• Excellent problem-solving skills, strategic thinking, and ability to work in a fast-paced, collaborative environment.
• Outstanding interpersonal skills, self-awareness, and ability to manage team dynamics.
• Ideally, has worked in more than one therapeutic area and has direct experience with innovative Phase 1-3 clinical study designs for oncology.
• Comfort with model-based drug development and agile drug development is important.
• Appreciation for observational methodologies is preferred.
• Ability to articulate complex methodologies to senior executives for their understanding is required with previous experience with presenting to senior executives being ideal.
• Demonstrated use of AI tools in your current role and responsibilities is required. Advanced or innovated use of AI is a strong plus.

Core Values

Parabilis is a team of passionate pioneers who are trailblazing the future of precision medicine with the aim of making a meaningful difference in the lives of patients. The company is committed to promoting an inspiring and flourishing working environment for all employees across the business, in all departments, and driving innovation for patient benefit.

• Growth-Minded. We’re inventing a new class of medicines—one applicable to therapeutic targets that have been dreamt about, but always considered impossible to drug. Our work requires us to be curious, humble and adaptable.
• In(ter)dependent.We are fiercely independent as a leader in defying the limitations of current therapeutic modalities, and interdependent as a team as we work collaboratively to shift drug discovery paradigms and provide patients with better treatment options.
• Patient-focused.We are deeply focused on patient outcomes, and all energy in the company is focused on science as it translates to patient impact.
• All-In.We’re All-In on solving some of the hardest scientific challenges and delivering one of the most effective new classes of drugs in history.

The base salary target for this position is $340,000-$380,000 per year, depending on experience, qualifications, and internal practices. Parabilis’s total compensation package also includes an annual target bonus, equity, and a comprehensive suite of competitive benefits designed to support our employees’ overall well-being.

As an equal opportunity employer, Parabilis values an inclusive workplace and welcomes applicants of all backgrounds and experiences. All qualified applicants will receive consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other factors prohibited by law.

30 Acorn Park Drive    |     Cambridge, MA 02140    |    www.parabilismed.com

Why Join Us?

Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines that unlock high-impact protein targets long-considered undruggable. The company has developed a new class of stabilized, cell-penetrant alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that are inaccessible to traditional drug modalities. 

Headquartered in Cambridge, Mass., Parabilis is advancing a focused pipeline of multiple first-in-class therapies across both rare and common cancers. Its lead candidate, FOG-001, is the first direct inhibitor of the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors, implicated in colorectal cancer, desmoid tumors, and a range of other Wnt/β-catenin-driven tumors. Parabilis is also advancing investigational degraders of ERG and ARON for the treatment of prostate cancer, as well as other preclinical programs. 

What’s the opportunity?

We are seeking an experienced industry nonclinical pharmacology leader with a demonstrated track record of advancing oncology programs from discovery through IND submission. This role will serve as the nonclinical pharmacology lead on one or more oncology programs, accountable for nonclinical pharmacology strategy, including translational planning and IND-enabling study design, and contributing to regulatory pharmacology content. You will be expected to meaningfully contribute to regulatory filings and identify translational forward approaches that target early clinical development goals.

Your leadership experience and history of working in a highly matrixed cross functional environment will be key in continuing to move oncology programs forward in a collaborative and scientifically rigorous environment. You will work within the existing pharmacology team framework and report directly to the Head of Pharmacology. Success in this role will require excellent communication, scientific thought leadership, a desire to work in a fast paced team environment and an eagerness to grow as a drug hunter.

Key abilities of this role include:

• Lead nonclinical pharmacology strategy for assigned oncology programs from late discovery through IND submission
• Design, oversee, interpret, and communicate in vivo PK/PD and efficacy studies (internally and via CRO partnerships)
• Contribute to IND-enabling study design and author or co-author relevant pharmacology sections of regulatory submissions
• Integrate pharmacology data with DMPK, safety, and biomarker findings to inform development decisions
• Clearly present data and strategy updates to senior leadership and governance teams
• Inspire and mentor junior pharmacology team members

What you’ll need to be successful:

• PhD. in Pharmacology, Biology, or related field with 8+ years post-degree experience with a minimum of 2+ years of program leadership and people management experience
• Experience supporting first-in-class or novel mechanism oncology programs
• Experience working with small molecules, peptides, degraders (e.g., PROTACs), or biologics
• Demonstrated success advancing at least one oncology program to development candidate nomination; experience contributing to an IND submission required
• Strong expertise in in vivo pharmacology, PK/PD modeling concepts, and mechanistic biomarker strategy
• Proven ability to independently design and interpret studies that support program milestones
• Demonstrated ability to utilize AI tools for day-to-day work; baseline proficiency is expected, and advanced or innovated use of AI is a strong plus
• Able to work on-site and attend in-person meetings
• Enthusiastic and innovative mindset with the ability to thrive in a dynamic, fast-pasted, and highly collaborative environment
• Excellent communication, organization, multi-tasking, flexibility, and team skills.

Core Values

Parabilis is a team of passionate pioneers who are trailblazing the future of precision medicine with the aim of making a meaningful difference in the lives of patients. The company is committed to promoting an inspiring and flourishing working environment for all employees across the business, in all departments, and driving innovation for patient benefit.

• Growth-Minded. We’re inventing a new class of medicines—one applicable to therapeutic targets that have been dreamt about, but always considered impossible to drug. Our work requires us to be curious, humble and adaptable.
• In(ter)dependent.We are fiercely independent as a leader in defying the limitations of current therapeutic modalities, and interdependent as a team as we work collaboratively to shift drug discovery paradigms and provide patients with better treatment options.
• Patient-focused.We are deeply focused on patient outcomes, and all energy in the company is focused on science as it translates to patient impact.
• All-In.We’re All-In on solving some of the hardest scientific challenges and delivering one of the most effective new classes of drugs in history.

The base salary target for this position is $165,000 - $200,000 per year, depending on experience, qualifications, and internal practices. Parabilis’s total compensation package also includes an annual target bonus, equity, and a comprehensive suite of competitive benefits designed to support our employees’ overall well-being.

Why Join Us?

Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines that unlock high-impact protein targets long-considered undruggable. The company has developed a new class of stabilized, cell-penetrant alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that are inaccessible to traditional drug modalities. 

Headquartered in Cambridge, Mass., Parabilis is advancing a focused pipeline of multiple first-in-class therapies across both rare and common cancers. Its lead asset, zolucatetide (FOG-001), is a first-in-class, clinically validated direct inhibitor of the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors, implicated in millions of cancer cases annually, including in colorectal cancer, desmoid tumors, hepatocellular carcinoma and a range of other Wnt/β-catenin-driven tumors. In Phase 1 clinical trials, zolucatetide produced the first-ever clinical evidence that it can directly inhibit this interaction, once previously considered “undruggable” despite its role across multiple cancer types. Parabilis is also advancing investigational degraders of ERG and AR^ON into clinical development for the treatment of prostate cancer, as well as progressing other preclinical programs. Backed by a recent $305 million Series F financing, Parabilis is entering an exciting phase of growth and execution.

What’s the opportunity?

Parabilis Inc. is seeking a highly talented and motivated Senior Data Scientist / Cheminformatician to support the platform discovery engine for Helicon^TM peptide drugs. Reporting to the Associate Director of Cheminformatics, the candidate will work collaboratively with biologists and chemists, leveraging skills in data science and cheminformatics to enable hypothesis generation and data insights for advancing Fog preclinical drug discovery.

You’ll be part of a data science team that is a central pillar of Parabilis’s innovative discovery platform and pipelines targeting “undruggable” genes of major therapeutic interest to patients. Our data science team is an integrated team ranging from computational biology, bioinformatics, computational drug discovery, research informatics and data engineering. We work at the interface of chemistry, biology, clinical and computational sciences, and are responsible for all aspects of data science from building the discovery pipeline to supporting and developing our discovery platform.

Responsibilities

• Provide scientific leadership and data science / (chem)informatics expertise towards, but not limited to, hit identification, targeted screening of Helical peptide library designs, hit prioritization, hit-to-lead progression using multi-objective optimization, new drug-target assessments, and advancing drug-pipeline projects towards the clinic
• Analyze peptide/chemical structure and property space to identify patterns / gaps that inform Helicon and monomer designs
• Adapt and implement data analytics and machine learning techniques towards predictive models of Helicon^TM properties
• Contribute to implementation and development of cheminformatics and research informatics systems and tools for Fog
• Work with IT and data engineering to enable enterprise-level cheminformatics solutions

Requirements

• MS or PhD in Data Science, Cheminformatics, Computational Chemistry or Computational Biology, Chemistry, Biophysics, Macromolecular sciences, Computer Science, or related scientific field with 5+ years of experience within the pharmaceutical or biotechnology field
• Proven track record of impact in a drug discovery program using informatics/computational techniques
• Demonstrated expertise with cheminformatics (e.g. RDKit, ICM, OEChem) and data science toolkits/libraries (e.g. Pandas, Scikit-Learn, and Numpy)
• Demonstrated understanding of critical assessment of molecule-property data and predictive model quality
• Demonstrated expertise in data analytics and solid grasp of statistical principles
• Experience with data visualization techniques and exploration tools (e.g Vortex, Spotfire, Datawarrior, DataGrok)
• Strong scientific programming skills (Python). Familiarity with modern pipeline tools is a plus.
• Excellent communication and collaboration skills that contribute to and inspire a vibrant community of drug hunters
• Experience with (chem)informatics analyses of peptides, machine learning, databases/enterprise informatics systems (e.g. Dotmatics), or cloud computing environments (e.g. Google, AWS, Azure) is a plus

Core Values

Parabilis is a team of passionate pioneers who are trailblazing the future of precision medicine with the aim of making a meaningful difference in the lives of patients. The company is committed to promoting an inspiring and flourishing working environment for all employees across the business, in all departments, and driving innovation for patient benefit.

• Growth-Minded. We’re inventing a new class of medicines—one applicable to therapeutic targets that have been dreamt about, but always considered impossible to drug. Our work requires us to be curious, humble and adaptable.
• In(ter)dependent.We are fiercely independent as a leader in defying the limitations of current therapeutic modalities, and interdependent as a team as we work collaboratively to shift drug discovery paradigms and provide patients with better treatment options.
• Patient-focused.We are deeply focused on patient outcomes, and all energy in the company is focused on science as it translates to patient impact.
• All-In.We’re All-In on solving some of the hardest scientific challenges and delivering one of the most effective new classes of drugs in history.

The base salary target for this position is $145,000 -$ 175,000 per year, depending on experience, qualifications, and internal practices. Parabilis’s total compensation package also includes an annual target bonus, equity, and a comprehensive suite of competitive benefits designed to support our employees’ overall well-being. 

As an equal opportunity employer, Parabilis Medicines values an inclusive workplace and welcomes applicants of all backgrounds and experiences. All qualified applicants will receive consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other factors prohibited by law.

Why Join Us?

As a member of the Parabilis Medicines team, you will be a part of an organization dedicated to creating extraordinary medicines for diseases with urgent unmet needs, harnessing our proprietary peptide platform to transform treatment possibilities for patients. Parabilis is a clinical-stage biopharmaceutical company dedicated to unlocking high-impact protein targets long-considered undruggable. The company has developed a new class of stabilized, cell-penetrant alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that are inaccessible to traditional drug modalities.

Headquartered in Cambridge, Mass., Parabilis is advancing a focused pipeline of multiple first-in-class therapies across both rare and common cancers. Its lead asset, zolucatetide (FOG-001), is a first-in-class, clinically validated direct inhibitor of the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors, implicated in millions of cancer cases annually, including in colorectal cancer, desmoid tumors, hepatocellular carcinoma and a range of other Wnt/β-catenin-driven tumors. In Phase 1 clinical trials, zolucatetide produced the first-ever clinical evidence that it can directly inhibit this interaction, once previously considered “undruggable” despite its role across multiple cancer types. Parabilis is also advancing investigational degraders of ERG and ARON into clinical development for the treatment of prostate cancer, as well as progressing other preclinical programs. Backed by a recent $305 million Series F financing, Parabilis is entering an exciting phase of growth and execution.

What’s the opportunity?

Parabilis Medicines is seeking a highly skilled and experienced Senior Director of Program Management with a robust background in oncology drug development.  This strategic program managerial role will be responsible for overseeing the planning, execution and delivery of early and mainly late-stage oncology programs, ensuring that projects align with our strategic objectives and are completed on time and within budget.  The Senior Director will coordinate cross-functional teams with the Global Project Team (GPT), drive project strategy in coordination with the Program Development Team Leader (PDTL) , and foster communication across the organization.

• Program planning and its execution: Assist the GPT to build and maintain the Integrated Development Strategy Plan and its integrated timelines, track progress against milestones, integrate cross-functional data to help inform decision making, ensure cross-functional awareness and readiness for key activities
• Risk & budget Management: Identify and mitigate project risks proactively, developing contingency plans to address potential challenges and ensure project success, escalate critical issues with options and team recommendations, assist in managing program budgets and budget forecasting
• Regulatory: Partner with regulatory team to prepare Health Authorities meetings and submission planning and execution
• Governance: Coordinate with the GPT to prepare material for governance committees, summarize actions, decisions and ensure follow-up
• PTDL coordination: partner to manage the GPT, support the PDTL in ensuring execution of programs decision and strategies
• Cross-Functional team management: Collaborate with key stakeholders across various functions, including clinical development, clinical operations, regulatory affairs, CMC, finance, commercial, and quality assurance—to ensure effective project execution and alignment.
• Performance Monitoring: Establish key performance indicators (KPIs) and metrics to monitor project progress, providing regular updates to executive leadership and stakeholders.

What you’ll need to be successful:

• Bachelor’s degree in Life Sciences, Pharmacy, or a related field required; advanced degree (e.g., MBA, PhD) preferred.
• 12+ years of project management experience in the biopharmaceutical industry, with a minimum of 5 years in a leadership role focused on oncology drug development.
• Proven track record of successfully managing complex oncology projects through all phases of development, including preclinical and clinical trials.
• Strong understanding of regulatory requirements and industry standards related to drug development and commercialization.
• Exceptional leadership, communication, and interpersonal skills, with the ability to influence and engage senior stakeholders and cross-functional teams.
• Demonstrated ability to think strategically and translate strategies into actionable plans.
• Proficient in project management methodologies and tools (e.g., MS Project, Asana, Trello); PMP or equivalent certification is preferred.
• Strong analytical and problem-solving skills, with a focus on achieving results in a fast-paced environment
• Demonstrated use of AI tools in your current role and responsibilities is required. Advanced or innovated use of AI is a strong plus.

Core Values

Parabilis Medicines is a team of passionate pioneers who are trailblazing the future of precision medicine with the aim of making a meaningful difference in the lives of patients. The company is committed to promoting an inspiring and flourishing working environment for all employees across the business, in all departments, and driving innovation for patient benefit.

• Growth-Minded. We’re inventing a new class of medicines—one applicable to therapeutic targets that have been dreamt about, but always considered impossible to drug. Our work requires us to be curious, humble and adaptable.
• In(ter)dependent. We are fiercely independent as a leader in defying the limitations of current therapeutic modalities, and interdependent as a team as we work collaboratively to shift drug discovery paradigms and provide patients with better treatment options.
• Patient-focused. We are deeply focused on patient outcomes, and all energy in the company is focused on science as it translates to patient impact.
• All-In. We’re All-In on solving some of the hardest scientific challenges and delivering one of the most effective new classes of drugs in history.

The base salary target for this position is $260,000-300,000, depending on experience, qualifications, and internal practices. Parabilis’s total compensation package also includes an annual target bonus, equity, and a comprehensive suite of competitive benefits designed to support our employees’ overall well-being.

As an equal opportunity employer, Parabilis Medicines values an inclusive workplace and welcomes applicants of all backgrounds and experiences. All qualified applicants will receive consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other factors prohibited by law.

30 Acorn Park Drive    |     Cambridge, MA 02140    |    www.parabilismed.com

Why Join Us?

As a member of the Parabilis Medicines team, you will be a part of an organization dedicated to creating extraordinary medicines for diseases with urgent unmet needs, harnessing our proprietary peptide platform to transform treatment possibilities for patients. Parabilis is a clinical-stage biopharmaceutical company dedicated to unlocking high-impact protein targets long-considered undruggable. The company has developed a new class of stabilized, cell-penetrant alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that are inaccessible to traditional drug modalities. 

Headquartered in Cambridge, Mass., Parabilis is advancing a focused pipeline of multiple first-in-class therapies across both rare and common cancers. Its lead asset, zolucatetide (FOG-001), is a first-in-class, clinically validated direct inhibitor of the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors, implicated in millions of cancer cases annually, including in colorectal cancer, desmoid tumors, hepatocellular carcinoma and a range of other Wnt/β-catenin-driven tumors. In Phase 1 clinical trials, zolucatetide produced the first-ever clinical evidence that it can directly inhibit this interaction, once previously considered “undruggable” despite its role across multiple cancer types. Parabilis is also advancing investigational degraders of ERG and AR^ON into clinical development for the treatment of prostate cancer, as well as progressing other preclinical programs. Backed by a recent $305 million Series F financing, Parabilis is entering an exciting phase of growth and execution.

What’s the opportunity?

We are seeking a highly talented and self-motivated person to contribute to the development of the Computational Drug Discovery group, a strategic function in Data Science that is part of Parabilis’s platform discovery engine for HeliconTM stapled-peptide drugs.  The skill sets of the group includes state-of-the-art machine learning/generative AI, molecular modeling, cheminformatics and data science towards the discovery and development of HeliconTM stapled-peptide drugs.

You’ll be part of a data science team that is a central pillar of Parabilis’s innovative discovery platform and pipelines targeting “undruggable” genes of major therapeutic interest to patients. Our data science team is an integrated team, ranging from computational biology, bioinformatics, computational drug discovery, research informatics and engineering. We work at the interface of chemistry, biology, clinical and computational sciences, and are responsible for all aspects of data science, from building the discovery pipeline to supporting and developing our discovery .

Responsibilities

• Provide computational expertise towards, but not limited to, ternary complex designs for degraders and other proximity-based modalities, hit-to-lead progression using multi-objective optimization, initiating new projects, new drug-target assessments and advancing drug-pipeline projects towards the clinic.
• Identify, implement, and apply 3D modeling techniques for sampling HeliconTM peptide conformations in presence of a target, in ternary complex, and in different physiological environments.
• Analyze and derive 3D peptide-structure relationships.
• Exemplify scientific leadership by partnering across functions and working within a team of talented and passionate scientists to discover drugs.
• Interface with internal and external partners.

What you’ll need to be successful:

• PhD in Computational Chemistry, Protein Engineering, Chemistry, Physics, Macromolecular sciences or close-related field
• 5+ years of pharma/biotech industry experience in computational rational drug .
• Demonstrated experience with ternary complex design and understanding, peptide design or protein engineering and a good understanding of peptide structure-property relationships (e.g. helicity and amphiphilicity metrics, cell penetration).
• Demonstrated mastery of modern computational chemistry including, but not limited to, peptide folding and docking, use of co-folding foundation models, such as Boltz, structure-based design (receptor and ligand-based), scaffold hopping, docking and conformational analysis.
• An understanding of modern drug discovery including, but not limited to, medicinal chemistry, multi-parametric optimization, molecular recognition principles, and the ability to adapt and translate these principles to stapled peptides.
• Excellent communication and collaboration skills, with the ability to work well in a multidisciplinary environment
• Excellent organizational skills and attention to detail, with a strong passion for learning new concepts and technologies
• Expertise in one or more peptide modeling environments (e.g. ICM, Rosetta, Amber, GROMACS) and methods (enhanced sampling MD, Monte Carlo, MSM).
• Demonstrated understanding of critical assessment of molecule-property data and predictive model quality.
• Demonstrated understanding of experiments behind the data that can be translated to computational analysis.
• Experience with command line modeling applications.
• Familiarity with cloud computing environments.
• Strong scientific programming skills (Python) in a Linux environment.
• Experience with enterprise research informatics systems such as Dotmatics and chemical and biological data warehouses is a plus.
• Familiarity with concepts in machine learning.
• Familiarity with cheminformatics techniques is a plus.
• Familiarity with use of LLMs and IDEs, such as Cursor, to enhance workflows, productivity and innovation is a plus.
• Demonstrated use of AI tools in your current role and responsibilities is required. Advanced or innovated use of AI is a strong plus.

Core Values

Parabilis is a team of passionate pioneers who are trailblazing the future of precision medicine with the aim of making a meaningful difference in the lives of patients. The company is committed to promoting an inspiring and flourishing working environment for all employees across the business, in all departments, and driving innovation for patient benefit.

• Growth-Minded. We’re inventing a new class of medicines—one applicable to therapeutic targets that have been dreamt about, but always considered impossible to drug. Our work requires us to be curious, humble and adaptable.
• In(ter)dependent.We are fiercely independent as a leader in defying the limitations of current therapeutic modalities, and interdependent as a team as we work collaboratively to shift drug discovery paradigms and provide patients with better treatment options.
• Patient-focused.We are deeply focused on patient outcomes, and all energy in the company is focused on science as it translates to patient impact.
• All-In.We’re All-In on solving some of the hardest scientific challenges and delivering one of the most effective new classes of drugs in history.

The base salary target for this position is $145,000 - $175,000 per year, depending on experience, qualifications, and internal practices. Parabilis’s total compensation package also includes an annual target bonus, equity, and a comprehensive suite of competitive benefits designed to support our employees’ overall well-being.

As an equal opportunity employer, Parabilis values an inclusive workplace and welcomes applicants of all backgrounds and experiences. All qualified applicants will receive consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other factors prohibited by law.

Why Join Us?

Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines that unlock high-impact protein targets long-considered undruggable. The company has developed a new class of stabilized, cell-penetrant alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that are inaccessible to traditional drug modalities. 

Headquartered in Cambridge, Mass., Parabilis is advancing a focused pipeline of multiple first-in-class therapies across both rare and common cancers. Its lead asset, zolucatetide (FOG-001), is a first-in-class, clinically validated direct inhibitor of the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors, implicated in millions of cancer cases annually, including in colorectal cancer, desmoid tumors, hepatocellular carcinoma and a range of other Wnt/β-catenin-driven tumors. In Phase 1 clinical trials, zolucatetide produced the first-ever clinical evidence that it can directly inhibit this interaction, once previously considered “undruggable” despite its role across multiple cancer types. Parabilis is also advancing investigational degraders of ERG and AR^ON into clinical development for the treatment of prostate cancer, as well as progressing other preclinical programs. Backed by a recent $305 million Series F financing, Parabilis is entering an exciting phase of growth and execution.

What’s the opportunity?

The Research Equipment Lead is responsible for enabling Parabilis’ cutting-edge research by ensuring laboratory equipment is strategically selected, optimally configured, highly reliable, and continuously improving. This role owns the full lifecycle of research instrumentation and partners closely with Research, Finance, Facilities, IT, Quality, and external vendors to minimize downtime, enable automation, and support scalable, reproducible science.

This position requires deep and broad technical expertise across research equipment platforms, strong operational rigor, and the ability to integrate automation, data, and AI-driven approaches into lab operations. The Research Equipment Lead plays a critical role in aligning equipment strategy with scientific roadmaps, growth plans, and financial and regulatory requirements.

Equipment Lifecycle & Operational Excellence

• Own the full lifecycle of research equipment, from needs assessment and acquisition through installation, operation, maintenance, and retirement, ensuring high availability and performance across research groups.
• Oversee day-to-day equipment operations, including troubleshooting, repairs, and preventive maintenance programs to minimize downtime and disruption to research.
• Lead installation, qualification, validation, and calibration of laboratory instruments in coordination with vendors, Facilities, IT, and internal stakeholders, applying continuous improvement principles.
• Maintain comprehensive, audit-ready documentation, including equipment inventories, maintenance logs, calibration records, service contracts, and validation documentation, in alignment with internal policies and applicable regulatory expectations.
• Establish and monitor key performance indicators (KPIs) for equipment reliability, utilization, and downtime.

Training, Partnership & Vendor Management

• Serve as the primary point of contact for equipment-related issues across research labs.
• Develop and deliver technical training to ensure safe, effective, and compliant use of laboratory instruments.
• Build strong cross-functional partnerships with Research, Facilities, IT, Quality, Procurement, and Finance to ensure seamless equipment support and alignment.
• Manage vendor relationships, including service agreements, performance reviews, and escalation of technical issues.

Equipment Strategy, Automation & Capital Planning

• Partner with R&D leadership to forecast equipment, automation, and digital infrastructure needs aligned with scientific strategy, growth plans, and budget constraints.
• Collaborate with Finance on capital planning, asset tracking, depreciation, and accounting requirements for research equipment.
• Evaluate emerging technologies, automation platforms, and AI-enabled tools; recommend capital investments that improve efficiency, scalability, data quality, and reproducibility.
• Identify opportunities to implement laboratory automation, robotics, and software-driven workflows, including the use of AI or data analytics to optimize equipment performance, scheduling, predictive maintenance, and experimental throughput.
• Contribute to the design or customization of novel or integrated instrumentation solutions to support next-generation research.

What you’ll need to be successful:

• Bachelor’s degree in Engineering, Life Sciences, Chemistry, Physics, or a related technical discipline; advanced degree preferred.
• 5-7+ years of hands-on experience supporting and maintaining complex research laboratory equipment across multiple scientific functions.
• Demonstrated expertise in equipment lifecycle management, preventive maintenance programs, and vendor coordination.
• Working knowledge of relevant scientific, engineering, operational, safety, and regulatory principles applicable to research laboratories.
• Strong organizational skills with exceptional attention to detail and documentation rigor.
• Proven ability to collaborate cross-functionally and communicate effectively with technical and non-technical stakeholders.
• Experience implementing laboratory automation, robotics, or digitally enabled workflows.
• Familiarity with AI- or data-driven approaches to equipment monitoring, utilization, or predictive maintenance.
• Experience partnering with Finance on capital equipment planning, budgeting, and accounting processes preferred.
• Demonstrated ability to utilize AI tools for day-to-day work; baseline proficiency is expected, and advanced or innovated use of AI is a strong plus
• Able to work on-site and attend in-person meetings

Core Values

Parabilis is a team of passionate pioneers who are trailblazing the future of precision medicine with the aim of making a meaningful difference in the lives of patients. The company is committed to promoting an inspiring and flourishing working environment for all employees across the business, in all departments, and driving innovation for patient benefit.

• Growth-Minded. We’re inventing a new class of medicines—one applicable to therapeutic targets that have been dreamt about, but always considered impossible to drug. Our work requires us to be curious, humble and adaptable.
• In(ter)dependent.We are fiercely independent as a leader in defying the limitations of current therapeutic modalities, and interdependent as a team as we work collaboratively to shift drug discovery paradigms and provide patients with better treatment options.
• Patient-focused.We are deeply focused on patient outcomes, and all energy in the company is focused on science as it translates to patient impact.
• All-In.We’re All-In on solving some of the hardest scientific challenges and delivering one of the most effective new classes of drugs in history.

The base salary target for this position is $86,000-$110,000 per year, depending on experience, qualifications, and internal practices. Parabilis’s total compensation package also includes an annual target bonus, equity, and a comprehensive suite of competitive benefits designed to support our employees’ overall well-being.

As an equal opportunity employer, Parabilis values an inclusive workplace and welcomes applicants of all backgrounds and experiences. All qualified applicants will receive consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other factors prohibited by law.

Why Join Us?

As a member of the Parabilis Medicines team, you will be a part of an organization dedicated to creating extraordinary medicines for diseases with urgent unmet needs, harnessing our proprietary peptide platform to transform treatment possibilities for patients. Parabilis is a clinical-stage biopharmaceutical company dedicated to unlocking high-impact protein targets long-considered undruggable. The company has developed a new class of stabilized, cell-penetrant alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that are inaccessible to traditional drug modalities. 

Headquartered in Cambridge, Mass., Parabilis is advancing a focused pipeline of multiple first-in-class therapies across both rare and common cancers. Its lead asset, zolucatetide (FOG-001), is a first-in-class, clinically validated direct inhibitor of the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors, implicated in millions of cancer cases annually, including in colorectal cancer, desmoid tumors, hepatocellular carcinoma and a range of other Wnt/β-catenin-driven tumors. In Phase 1 clinical trials, zolucatetide produced the first-ever clinical evidence that it can directly inhibit this interaction, once previously considered “undruggable” despite its role across multiple cancer types. Parabilis is also advancing investigational degraders of ERG and AR^ON into clinical development for the treatment of prostate cancer, as well as progressing other preclinical programs. Backed by a recent $305 million Series F financing, Parabilis is entering an exciting phase of growth and execution.

What’s the opportunity?

Parabilis is seeking an accomplished Associate Director of Medicinal Chemistry – Synthesis with deep expertise in small-molecule synthesis to lead a team advancing compounds from hit identification through lead optimization and candidate nomination. This leader will apply innovative synthetic strategies, data-driven execution, and strong cross-functional collaboration to accelerate high-impact discovery programs.

The successful candidate will provide scientific and strategic leadership, mentor and develop synthesis chemists, and play a critical role in advancing the company’s portfolio.

You will join a medicinal chemistry synthesis team that is central to Parabilis’s discovery engine and pipeline, focused on therapeutically important and historically “undruggable” targets. This individual will lead synthesis efforts across Helicon degrader programs and collaborate closely with Chemistry Design, Biology, Data Science, and Computational Science teams. The role includes full ownership of synthesis strategy and execution, with opportunities to lead cross-functional program teams in delivering development candidates.

Key Responsibilities

• Lead medicinal chemistry synthesis teams utilizing innovative, state-of-the-art synthetic technologies to rapidly generate small-molecule fragments, E3 ligands, and complex degraders
• Design and execute efficient synthetic routes from simple building blocks to structurally complex molecules
• Develop, implement, and clearly communicate integrated synthesis strategies in partnership with Design, Data Science, De Novo Discovery, Molecular & Cellular Biology, DMPK, and Pharmacology teams to achieve hit-to-lead and lead optimization milestones
• Drive data-informed decision-making to accelerate compound synthesis progression
• Manage and cultivate productive partnerships with external CRO collaborators
• Partner closely with internal synthesis and purification teams to streamline workflows and accelerate molecule delivery timelines
• Mentor, coach, and develop team members while fostering a culture of scientific rigor, innovation, accountability, and collaboration

What you’ll need to be successful:

• Ph.D. in Chemistry with 8+ years of industry experience in pharmaceutical or biotechnology settings
• Demonstrated expertise in synthetic route design and execution across a range of molecular complexity
• Strong background in synthetic methodology development, complex problem solving, and modern small-molecule synthesis
• Experience being synthesis lead in projects and managing external CRO partnerships
• Proven leadership ability with experience influencing cross-functional teams
• Innovative thinker with a growth mindset and willingness to challenge conventional approaches
• Passion for drug discovery and advancing novel therapeutic modalities
• Excellent communication, organizational, and collaboration skills
• Ability to independently prioritize and deliver against timelines aligned with company objectives
• Thrives in a dynamic, fast-paced research environment
• Willingness to work on-site and participate in in-person meetings
• Experience in solid-phase peptide synthesis is preferred
• Able to work on-site and attend in-person meetings
• Demonstrated use of AI tools in your current role and responsibilities is required. Advanced or innovative use of AI is a strong plus.

Core Values

Parabilis is a team of passionate pioneers who are trailblazing the future of precision medicine with the aim of making a meaningful difference in the lives of patients. The company is committed to promoting an inspiring and flourishing working environment for all employees across the business, in all departments, and driving innovation for patient benefit.

• Growth-Minded. We’re inventing a new class of medicines—one applicable to therapeutic targets that have been dreamt about, but always considered impossible to drug. Our work requires us to be curious, humble and adaptable.
• In(ter)dependent.We are fiercely independent as a leader in defying the limitations of current therapeutic modalities, and interdependent as a team as we work collaboratively to shift drug discovery paradigms and provide patients with better treatment options.
• Patient-focused.We are deeply focused on patient outcomes, and all energy in the company is focused on science as it translates to patient impact.
• All-In.We’re All-In on solving some of the hardest scientific challenges and delivering one of the most effective new classes of drugs in history.

The base salary target for this position is $165,000 - $200,000 per year, depending on experience, qualifications, and internal practices. Parabilis’s total compensation package also includes an annual target bonus, equity, and a comprehensive suite of competitive benefits designed to support our employees’ overall well-being.

As an equal opportunity employer, Parabilis values an inclusive workplace and welcomes applicants of all backgrounds and experiences. All qualified applicants will receive consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other factors prohibited by law.

Why Join Us?

Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines that unlock high-impact protein targets long-considered undruggable. The company has developed a new class of stabilized, cell-penetrant alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that are inaccessible to traditional drug modalities. 

Headquartered in Cambridge, Mass., Parabilis is advancing a focused pipeline of multiple first-in-class therapies across both rare and common cancers. Its lead candidate, FOG-001, is the first direct inhibitor of the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors, implicated in colorectal cancer, desmoid tumors, and a range of other Wnt/β-catenin-driven tumors. Parabilis is also advancing investigational degraders of ERG and ARON for the treatment of prostate cancer, as well as other preclinical programs. 

What’s the opportunity?

This role is the primary computational partner for one or more pipeline programs, working across both preclinical and clinical spaces to convert complex biomarker, mechanistic, and RWD/E datasets into clear, actionable insights for target, dose, indication, and combination strategy. Reporting to the Head of Computational Biology, a successful candidate will design and implement robust analysis workflows spanning in vitro and in vivo studies, early‑phase trials, and external data sources to refine patient selection and mechanism‑of‑action understanding. The ideal candidate will couple their prior experience in oncology with a deep understanding of bioinformatics methodologies, a strong computational skill set, and an ability to translate scientific challenges into technical solutions and analysis that informs team decisions.

Scope of the role:

• Strategic thinker, planner and implementer of computational biomarker and translational analyses for early‑phase oncology studies (e.g., FOG‑001 and ERG/AR degraders), from IND‑enabling work through Phase 1/2, ensuring continuity between preclinical and clinical datasets.
• Design and execute analysis plans for diverse biomarker modalities across preclinical models and clinical samples, including bulk and single‑cell RNA‑seq, DNA panels/WES, ctDNA, IHC/IF, multiplex protein assays, and other exploratory readouts.
• Synthesize, summarize and communicate findings in a clear, decision‑oriented manner to cross‑functional teams and governance, and contribute to internal decision making, conference abstracts, and manuscripts as appropriate.

Who you’ll be working with:

• Partner closely with discovery biology, translational scientists, clinicians, biostatistics, and RWD/E colleagues to define questions that leverage both preclinical and human data, and to design analyses that are statistically and biologically robust

Main tasks & duties for the position:

• Analyze preclinical in vitro and in vivo data (e.g., Helicon screens, xenograft/PDX models, pharmacology and PD studies) to characterize target engagement, pathway modulation, and resistance mechanisms, and translate these findings into clinical hypotheses.
• Analyze pre and on treatment patient biopsies and blood samples to quantify pathway modulation, signaling changes, and emergent resistance or sensitivity signatures, integrating with preclinical findings where possible.
• Develop, validate, and operationalize predictive and pharmacodynamic biomarker signatures for use in preclinical strategy, trial design, and RWD/E anchored analyses, including patient stratification and indication/expansion cohort selection
• Uses leading-edge knowledge of principles, concepts and practices and/or techniques to lead complex projects involving related departments; May have supervisory responsibilities

What you’ll need to be successful:

• PhD in Computational Biology, Bioinformatics, Statistics, Epidemiology, or related field, or MS with significant industry experience in translational, clinical biomarker, and/or RWD/E analysis in oncology.
• 7+ years of relevant post graduate experience (biotech/pharma or closely related), including direct work with both preclinical and clinical oncology datasets.
• Strong hands on experience analyzing biomarker data such as DNA sequencing, RNA seq (bulk and/or single cell), ctDNA, and tissue based assays (IHC/IF, multiplex platforms), with demonstrated impact on either discovery or development decisions, ideally both.
• Proficiency in Python and/or R, including data wrangling, statistical modeling, visualization, and best practices for reproducible research (version control, environments, documentation).
• Comfortable operating at the interface of discovery, translation, clinical development, and external data, with a track record of effective collaboration with non-computational colleagues.
• Excellent communication skills, with the ability to translate complex analyses into concise, decision ready narratives for diverse audiences.
• Demonstrated use of AI tools in your current role and responsibilities is required. Advanced or innovative use of AI is a strong plus.
• Able to work on-site and attend in-person meetings for the majority of time.

Core Values

Parabilis is a team of passionate pioneers who are trailblazing the future of precision medicine with the aim of making a meaningful difference in the lives of patients. The company is committed to promoting an inspiring and flourishing working environment for all employees across the business, in all departments, and driving innovation for patient benefit.

• Growth-Minded. We’re inventing a new class of medicines—one applicable to therapeutic targets that have been dreamt about, but always considered impossible to drug. Our work requires us to be curious, humble and adaptable.
• In(ter)dependent.We are fiercely independent as a leader in defying the limitations of current therapeutic modalities, and interdependent as a team as we work collaboratively to shift drug discovery paradigms and provide patients with better treatment options.
• Patient-focused.We are deeply focused on patient outcomes, and all energy in the company is focused on science as it translates to patient impact.
• All-In.We’re All-In on solving some of the hardest scientific challenges and delivering one of the most effective new classes of drugs in history.

The base salary target for this position is $175,000 - $220,000 per year, depending on experience, qualifications, and internal practices. Parabilis’s total compensation package also includes an annual target bonus, equity, and a comprehensive suite of competitive benefits designed to support our employees’ overall well-being.

As an equal opportunity employer, Parabilis values an inclusive workplace and welcomes applicants of all backgrounds and experiences. All qualified applicants will receive consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other factors prohibited by law.